<DOC>
	<DOCNO>NCT00839605</DOCNO>
	<brief_summary>The purpose study evaluate effect Dexmedetomidine use thoracic surgery . The primary outcome change oxygenation measure PaO2 one lung ventilation .</brief_summary>
	<brief_title>Dexmedetomidine Hypoxic Pulmonary Vasoconstriction Thoracic Surgical Procedures One-Lung Ventilation</brief_title>
	<detailed_description>To collect data effect Dexmedetomidine ( DEX ) ( 0.3mcg/kg load dose follow infusion 0.3mcg/kg/hr ) Hypoxic pulmonary vasoconstriction administer patient surgery one lung ventilate thoracic procedure . Dexmedetomidine vasoconstricting vasodilatatory effect peripheral vasculature effect pulmonary vessel know . If predominantly vasodilator pulmonary vessel inhibit hypoxic pulmonary vasoconstriction increase shunt venous blood arterial circulation without oxygenation . If study prof vasodilator pulmonary vessel wise use thoracic procedure one lung ventilation . If study prof vasoconstrictor pulmonary vessel , excellent adjunct anesthetic agent one lung ventilation .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1 . Subject &gt; 18 year age . 2 . Subject American Society Anesthesiologists ( ASA ) Physical Status I , II , III , IV . 3 . If female , subject nonlactating either : Not childbearing potential , defined postmenopausal least 1 year surgically sterile due bilateral tubal ligation , bilateral oophorectomy hysterectomy . Of childbearing potential pregnant time baseline practice one follow method birth control : oral parenteral contraceptive , doublebarrier method , vasectomized partner , abstinence sexual intercourse . 4 . Subject require thoracic surgical procedure . 5 . Subject ( subject 's legally authorize representative ) voluntarily sign date informed consent document approve Institutional Review Board . 1 . Subject receive general anesthesia within 7 day prior study entry , receive experimental drug within 30 day prior study drug administration , previously enrol study . 2 . Subject central nervous system ( CNS ) disease anticipated potential increase intracranial pressure , uncontrolled seizure disorder and/or know psychiatric illness could confound normal response sedative treatment . 3 . Subject receive treatment alpha2 agonist antagonist within 14 day schedule surgery/procedure . 4 . Subject opiate , benzodiazepine , DEX alpha2 agonist contraindicate . 5 . Subject receive IV opioid within one hour , PO/IM opioid within four hour , start study drug administration . 6 . Subject acute unstable angina , acute myocardial infarction document laboratory finding past six week , heart rate &lt; 50 bpm , SBP &lt; 90 mmHg , thirddegree heart block unless patient pacemaker . 7 . Subject know elevated SGPT ( ALT ) and/or SGOT ( AST ) value &gt; 2 time upper limit normal ( ULN ) within two month prior screen , and/or history liver failure . 8 . Subject condition factor , Investigator 's opinion , might increase risk subject . 9 . On vasodilator , i.e. , nitroglycerin , nitroprusside , ACE inhibitors 10. vasopressor , i.e , norepinephrine , epinephrine , vasopressin</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Thoracic surgery one lung ventilation</keyword>
	<keyword>airway reconstruction</keyword>
</DOC>